Myriad Genetics | MYGN - Gross Profit On Sales



Myriad Genetics reported $134.2M in Gross Profit on Sales for its fiscal quarter ending in March of 2025.


Gross Profit On Sales Change Date
Agilent USD 888M 22M Jul/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
Bruker USD 357.9M 33.3M Jun/2025
Danaher USD 3.52B 3M Jun/2025
Exact Sciences USD 562.45M 61.91M Jun/2025
Hologic USD 576.6M 15.9M Jun/2025
Illumina USD 695M 12M Jun/2025
J&J USD 14.6B 816M Mar/2025
Mettler Toledo International USD 579.88M 54M Jun/2025
Myriad Genetics USD 134.2M 16.7M Mar/2025
Quest Diagnostics USD 904M 35M Jun/2025
Quidel USD 227M 116.3M Jun/2025
Repligen USD 91.14M 385K Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
Standard Biotools USD 10.63M 11.28M Jun/2025
Thermo Fisher Scientific USD 4.05B 260M Jun/2025
Veracyte USD 89.77M 10.26M Jun/2025
Waters USD 438.02M 53.06M Jun/2025